Molnupiravir is expensive and pathetic, especially when compared against vitamin D: 2022 confirms 2021
New research proves that I was right a year ago
In 2022, new data again shows that Molnupiravir is pathetic and overpriced
In 2021, HealthyThinking subscribers knew first
Subscribers to my newsletter were the first (Oct2022)to see that Molnupiravir was a waste of money, and that vitamin D was superior.
The data on Merck’s molnupiravir was pathetic from the start, but America’s bribed politicians spent $$$BILLION on it anyway; by that same time (from Oct2022), the data on the benefits of vitamin D was already clear:
Ready for more information on Vitamin D? See these articles and videos:
Vitamin D supplementation must optimize blood levels of the active form of the vitamin—25-hydroxy-vitaminD: "It's not what you take, it's what you make." Dr Alex Vasquez [SHORT VIDEO]
Barrier defense against allergy and inflammation [VIDEO + ARTICLES] includes the history of my 2004 publication “The vitamin D paradigm shift for all healthcare providers” and the full-text PDF
Vitamin D in anti-inflammation and immunomodulation [VIDEO],
Vitamin D against infections; vitamin D supports antiviral defense [VIDEO],
Human papilloma virus (HPV) readily responds to Vitamin D despite fraudulent infomercials from the British Medical Journal (BMJ) [VIDEO EXCERPT]
F.A.C.I.L.E.© Pharmacology of Vitamin D in the Park with DrV
MOLNUPIRAVIR is 100x more expensive and 50% less effective compared against vitamin D [VIDEO EXCERPT] and “Molnupiravir is expensive and pathetic, especially when compared against vitamin D: 2022 confirms 2021”